Trial Profile
A Phase 1, Open-Label, Single-Sequence Drug Interaction Study to Evaluate the Effect of Multiple-Dose ASP015K on the Pharmacokinetics of Rosuvastatin in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2013
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary) ; Rosuvastatin
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 16 Oct 2013 New trial record